UBS Group’s Insulet PODD Stock Holding History

UBS Group’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-82,600	Closed	-$7.85M	–	8086
2019 Q1	$7.85M	Buy	+82,600	New	+$7.08M	﹤0.01%	1848

Other funds holding PODD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS Group's PODD Position: Q1 2026 in Review

UBS Group increased its Insulet (PODD) stake by 91% in Q1 2026, buying an estimated $53.3M and bringing the position to 445,939 shares worth $93.6M. The position accounts for 0.01% of the portfolio, ranked #1106.

UBS Group first reported a position in PODD in Q4 2014 and has held it in 46 quarters since. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

UBS Group held 445,939 shares of Insulet worth $93.6M as of Q1 2026.
UBS Group bought 211,917 Insulet shares in Q1 2026, an estimated $53.3M.
Insulet made up 0.01% of UBS Group's portfolio in Q1 2026, its #1106 holding.
UBS Group first reported a position in Insulet in Q4 2014 and has held it in 46 quarters since.
785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.